$KZIA Kazia Therapeutics $IBB $XBI Next week. Do the math

Paired trade idea: Sell $RVMD , buy $ACTU. Close the ridiculous gap. Actuate Therapeutics has gorgeous, impeccable mOS data. Thank me later $IBB $XBI

$KZIA ICYMI THIS WEEK NOW Kazia Therapeutics $IBB $XBI HODOR

$ACTU $RVMD $IMRX $IBB $XBI

$ACTU $ANL $IMRX $RVMD $IBB $XBI

Excellent snippet by $ACTU CEO Dan Schmidt and Lou Basenese . Stop being lazy and take a listen on this Elraglusib drug by Actuate Therapeutics Wake up $IBB $XBI $RVMD $IMRX $ANL $BMY $MRK $PFE $GILD $RHHBY actuatetherapeutics.com

$ACTU $IBB $XBI $RVMD $IMX $ANL $BMY $GILD $MRK Lou Basenese Varro Analytics 🇺🇸 John Carroll Adam May Avid Trader Steven Cohen $KZIA

$ACTU Actuate Therapeutics $RVMD $IMRX $ANL $IBB $XBI $GILD $BMY $MRK Lou Basenese clinicalleader.com/doc/becoming-a…

$KZIA Ikarian Capital discloses 5.1% Kazia Therapeutics (KZIA) ADS position Kazia Therapeutics $IBB $XBI $CELC stocktitan.net/sec-filings/KZ…

$KZIA See today's $SNSE comp

$KZIA The re-branded Kazia Therapeutics sits at the intersection of the sizzling Plk3/mTOR pathway space. An untold underfollowed story trading at a fraction of it's comps. No-brainer for a quick 5X. Possible 20X in next 12-18 months.Bulge bracket research incoming $CELC $SNSE $IBB $XBI

$CELC $SNSE $IBB $XBI $IBB $XBI Jorey Chernett boosts stake in Kazia Therapeutics to 12.46% excluding his pre-funded warrants which most likely takes his position north of 15%. Strong conviction by a saavy investor

$KZIA HODOR

$KZIA ICYMI Steven Cohen Lou Basenese Ripster Pharmdca dough $PFE $MRK $SNSE $CELC She wants to break out here TW Research Group $MSTR HODOR

$ACTU $IBB $XBI $RVMD $IMRX $ANL Lou Basenese

$KZIA ICYMI Steven Cohen $SNSE $CELC $IBB $XBI

$KZIA Leerink's name is on the Kazia Therapeutics $200 million shelf. I believe that's a good harbinger for a virtuous cycle for future coverage. $IBB $XBI sec.gov/Archives/edgar…